The central theme of this program project is the regulation of apolipoprotein metabolism and its physiologic role in lipid and lipoprotein homeostasis. To achieve this goal, we organized a multi-disciplinary approach involving physiology, biochemistry, immunochemistry, and cell biology, employing both in vivo and in vitro techniques. We propose the following broad areas of investigation: 1. To study peripheral lymph lipoprotein metabolism by: a) further characterization of """"""""interstitial"""""""" lipoproteins; b) examining the biogenesis of lipoprotein particles found to be unique to peripheral lymph; c) defining the metabolic fate of the unique, discoidal """"""""interstitial"""""""" HDL particle; d) examining the production of apo A-IV-containing particles by the intestine and liver and their role in interstitial fluid; and e) studying the mechanism of the formation in the interstitial fluid of apo A-I unassociated with conventional lipoprotein particles. 2. To study in vivo modification of lipoproteins in the circulation by: a) examining the remodeling of """"""""interstitial"""""""" lipoproteins and determining the processes involved; b) studying the dynamics of lipoprotein remodeling (particularly apo A-IV particles and apo A-I unassociated with lipoproteins) in plasma and peripheral lymph; c) examining how remodeling of plasma and lymph lipoproteins (their apolipoprotein and lipid components) influences their metabolism; and d) determining how this remodeling may be involved in reverse cholesterol transport. 3. To study apoprotein synthesis by : a) defining the biogenesis and molecular structure of apo B; b) determining the physiologic importance of apo B phosphorylation with regard to VLDL assembly/secretion; and c) determining the genetic expression of apo B caused by physiologic """"""""effectors."""""""" We are also studying apolipoprotein synthesis by peripheral tissues, both in vivo in vitro. We believe these studies will contribute to our understanding of lipoprotein-apoprotein metabolism and its physiologic role in lipid homeostasis.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Program Projects (P01)
Project #
5P01HL025596-10
Application #
3097890
Study Section
Heart, Lung, and Blood Research Review Committee B (HLBB)
Project Start
1980-04-01
Project End
1990-03-31
Budget Start
1989-04-01
Budget End
1990-03-31
Support Year
10
Fiscal Year
1989
Total Cost
Indirect Cost
Name
Louisiana State University Hsc New Orleans
Department
Type
School of Medicine & Dentistry
DUNS #
782627814
City
New Orleans
State
LA
Country
United States
Zip Code
70112
DeLamatre, J G; Gabaldon, D M; Arnold, C S et al. (1998) Hepatic metabolism of oxidatively modified apo E-free high-density lipoproteins. Liver 18:264-71
Asztalos, B; Zhang, W; Roheim, P S et al. (1997) Role of free apolipoprotein A-I in cholesterol efflux. Formation of pre-alpha-migrating high-density lipoprotein particles. Arterioscler Thromb Vasc Biol 17:1630-6
Asztalos, B F; Lefevre, M; Foster, T A et al. (1997) Normolipidemic subjects with low HDL cholesterol levels have altered HDL subpopulations. Arterioscler Thromb Vasc Biol 17:1885-93
Hornick, C A; Hui, D Y; DeLamatre, J G (1997) A role for retrosomes in intracellular cholesterol transport from endosomes to the plasma membrane. Am J Physiol 273:C1075-81
Lee, L T; Scheer, W D; Thompson, J J (1996) Identification of cryptic peanut agglutinin-reactive sites in human lipoprotein(a). Biochim Biophys Acta 1302:79-83
Wong, L; Sivok, B; Kurucz, E et al. (1995) Lipid composition of HDL subfractions in dog plasma and lymph. Arterioscler Thromb Vasc Biol 15:1875-81
Asztalos, B F; Roheim, P S (1995) Presence and formation of 'free apolipoprotein A-I-like' particles in human plasma. Arterioscler Thromb Vasc Biol 15:1419-23
Fu, D; Hornick, C A (1995) Modulation of lipid metabolism at rat hepatic subcellular sites by female sex hormones. Biochim Biophys Acta 1254:267-73
de Beer, M C; Yuan, T; Kindy, M S et al. (1995) Characterization of constitutive human serum amyloid A protein (SAA4) as an apolipoprotein. J Lipid Res 36:526-34
Roheim, P S; Asztalos, B F (1995) Clinical significance of lipoprotein size and risk for coronary atherosclerosis. Clin Chem 41:147-52

Showing the most recent 10 out of 63 publications